789
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Hop bioactive compounds in prevention of nutrition-related noncommunicable diseases

&

References

  • Albini, A., R. Dell'Eva, R. Vené, N. Ferrari, D. R. Buhler, D. M. Noonan, and G. Fassina. 2006. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets . FASEB Journal 20 (3):527–9. doi: 10.1096/fj.05-5128fje.
  • Ano, Y., R. Ohya, K. Kondo, and H. Nakayama. 2019. Iso-α-acids, hop-derived bitter components of beer, attenuate age-related inflammation and cognitive decline. Frontiers in Aging Neuroscience 11:16.
  • Ano, Y., M. Yoshikawa, Y. Takaichi, M. Michikawa, K. Uchida, H. Nakayama, and A. Takashima. 2019. Iso-α-acids, bitter components in beer, suppress inflammatory responses and attenuate neural hyperactivation in the hippocampus. Frontiers in Pharmacology 10:81.
  • Antharam, V. C., E. C. Li, A. Ishmael, A. Sharma, V. Mai, K. H. Rand, and G. P. Wang. 2013. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. Journal of Clinical Microbiology 51 (9):2884–92. doi: 10.1128/JCM.00845-13.
  • Avula, B., M. Ganzera, J. E. Warnick, M. W. Feltenstein, K. J. Sufka, and I. A. Khan. 2004. High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. Journal of Chromatographic Science 42 (7):378–82. doi: 10.1093/chromsci/42.7.378.
  • Ayabe, T., R. Ohya, K. Kondo, and Y. Ano. 2018. Iso-α-acids, bitter components of beer, prevent obesity-induced cognitive decline. Scientific Reports 8 (1):4760. doi: 10.1038/s41598-018-23213-9.
  • Balimane, P. V., S. Chong, and R. A. Morrison. 2000. Current methodologies used for evaluation of intestinal permeability and absorption. Journal of Pharmacological and Toxicological Methods 44 (1):301–12. doi: 10.1016/S1056-8719(00)00113-1.
  • Barquera, S., A. Pedroza-Tobías, C. Medina, L. Hernández-Barrera, K. Bibbins-Domingo, R. Lozano, and A. E. Moran. 2015. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Archives of Medical Research 46 (5):328–38. doi: 10.1016/j.arcmed.2015.06.006.
  • Bartelt, A., and J. Heeren. 2014. Adipose tissue browning and metabolic health. Nature Reviews Endocrinology 10 (1):24–36. doi: 10.1038/nrendo.2013.204.
  • Behre, K.-E. 1999. The history of beer additives in Europe — A review. Vegetation History and Archaeobotany 8 (1–2):35–48. doi: 10.1007/BF02042841.
  • Bischoff, S. C. 2011. 'Gut health': A new objective in medicine? BMC Medicine 9:24. doi: 10.1186/1741-7015-9-24.
  • Blatchford, P. A., S. G. Parkar, W. Hopkins, J. R. Ingram, and K. H. Sutton. 2019. Dose-dependent alterations to in vitro human microbiota composition and butyrate inhibition by a supercritical carbon dioxide hops extract. Biomolecules 9 (9):390. doi: 10.3390/biom9090390.
  • Bohr, G., K. Klimo, J. Zapp, H. Becker, and C. Gerhäuser. 2008. Cancer chemopreventive potential of humulones and isohumulones (hops α- and iso-α-acids): Induction of NAD(P)H:Quinone Reductase as a novel mechanism. Natural Products Communications. 3 (12):1971–6. doi: 10.1177/1934578X0800301206.
  • Bray, F., J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer journal for clinicians 68 (6):394–424. doi: 10.3322/caac.21492.
  • Candela, M., S. Rampelli, S. Turroni, M. Severgnini, C. Consolandi, G. De Bellis, R. Masetti, G. Ricci, A. Pession, and P. Brigidi. 2012. Unbalance of intestinal microbiota in atopic children. BMC Microbiology 12:95. doi: 10.1186/1471-2180-12-95.
  • Cattoor, K., M. Bracke, D. Deforce, D. De Keukeleire, and A. Heyerick. 2010. Transport of hop bitter acids across intestinal Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry 58 (7):4132–40. doi: 10.1021/jf904079h.
  • Cattoor, K., M. Dresel, L. De Bock, K. Boussery, J. Van Bocxlaer, J.-P. Remon, D. De Keukeleire, D. Deforce, T. Hofmann, and A. Heyerick. 2013. Metabolism of hop-derived bitter acids. Journal of Agricultural and Food Chemistry 61 (33):7916–24. doi: 10.1021/jf300018s.
  • Cattoor, K., J.-P. Remon, K. Boussery, J. V. Bocxlaer, M. Bracke, D. D. Keukeleire, D. Deforce, and A. Heyerick. 2011. Bioavailability of hop-derived iso-α-acids and reduced derivatives. Food & Function 2 (7):412–22. doi: 10.1039/c1fo10009b.
  • Cermak, P., J. Olsovska, A. Mikyska, M. Dusek, Z. Kadleckova, J. Vanicek, O. Nyc, K. Sigler, V. Bostikova, and P. Bostik. 2017. Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria. Acta Pathologica, Microbiologica et Immunologica Scandinavica 125 (11):1033–8. doi: 10.1111/apm.12747.
  • Chen, W.-J., and J.-K. Lin. 2004. Mechanisms of cancer chemoprevention by hop bitter acids (beer aroma) through induction of apoptosis mediated by Fas and caspase cascades. Journal of Agricultural and Food Chemistry 52 (1):55–64. doi: 10.1021/jf034737u.
  • Cho, J.-M., S.-M. Yun, Y.-H. Choi, J. Heo, N.-J. Kim, S.-H. Kim, and E.-H. Kim. 2018. Xanthohumol prevents dextran sulfate sodium-induced colitis via inhibition of IKKβ/NF-κB signaling in mice. Oncotarget 9 (1):866–80. doi: 10.18632/oncotarget.23183.
  • Cho, Y.-C., H. J. Kim, Y.-J. Kim, K. Y. Lee, H. J. Choi, I.-S. Lee, and B. Y. Kang. 2008. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. International Immunopharmacology 8 (4):567–73. doi: 10.1016/j.intimp.2007.12.017.
  • Colgate, E. C., C. L. Miranda, J. F. Stevens, T. M. Bray, and E. Ho. 2007. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Letters 246 (1–2):201–9. doi: 10.1016/j.canlet.2006.02.015.
  • Coskun, M., J. T. Troelsen, and O. H. Nielsen. 2011. The role of CDX2 in intestinal homeostasis and inflammation. Biochimica et Biophysica Acta 1812 (3):283–9. doi: 10.1016/j.bbadis.2010.11.008.
  • Costa, R., I. Rodrigues, L. Guardão, S. Rocha-Rodrigues, C. Silva, J. Magalhães, M. Ferreira-de-Almeida, R. Negrão, and R. Soares. 2017. Xanthohumol and 8-prenylnaringenin ameliorate diabetic-related metabolic dysfunctions in mice. The Journal of Nutritional Biochemistry 45:39–47. doi: 10.1016/j.jnutbio.2017.03.006.
  • Cuendet, M., C. P. Oteham, R. C. Moon, and J. M. Pezzuto. 2006. Quinone reductase induction as a biomarker for cancer chemoprevention. Journal of Natural Products 69 (3):460–3. doi: 10.1021/np050362q.
  • Cypess, A. M., L. S. Weiner, C. Roberts-Toler, E. F. Elía, S. H. Kessler, P. A. Kahn, J. English, K. Chatman, S. A. Trauger, A. Doria, et al. 2015. Activation of human brown adipose tissue by a β3-Adrenergic receptor agonist. Cell Metabolism 21 (1):33–8., doi: 10.1016/j.cmet.2014.12.009.
  • De Keukeleire, D. 2000. Fundamentals of beer and hop chemistry. Química Nova 23 (1):108–12. doi: 10.1590/S0100-40422000000100019.
  • De Keukeleire, J., G. Ooms, A. Heyerick, I. Roldan-Ruiz, E. Van Bockstaele, and D. De Keukeleire. 2003. Formation and accumulation of alpha-acids, beta-acids, desmethylxanthohumol, and xanthohumol during flowering of hops (Humulus lupulus L.). Journal of Agricultural and Food Chemistry 51 (15):4436–41. doi: 10.1021/jf034263z.
  • Dell'Eva, R., C. Ambrosini, N. Vannini, G. Piaggio, A. Albini, and N. Ferrari. 2007. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 110 (9):2007–11. doi: 10.1002/cncr.23017.
  • Dietz, B. M., Y. H. Kang, G. Liu, A. L. Eggler, P. Yao, L. R. Chadwick, G. F. Pauli, N. R. Farnsworth, A. D. Mesecar, R. B. van Breemen, et al. 2005. Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase. Chemical Research in Toxicology 18 (8):1296–305., doi: 10.1021/tx050058x.
  • Dong, J., X. Zhang, L. Zhang, H. X. Bian, N. Xu, B. Bao, and J. Liu. 2014. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: A mechanism including AMPKα1/SIRT1. Journal of Lipid Research 55 (3):363–74. doi: 10.1194/jlr.M038786.
  • Dorn, C., B. Kraus, M. Motyl, T. S. Weiss, M. Gehrig, J. Schölmerich, J. Heilmann, and C. Hellerbrand. 2010. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Molecular Nutrition & Food Research 54 (S2):S205–S213. doi: 10.1002/mnfr.200900314.
  • Drenzek, J. G., N. L. Seiler, R. Jaskula-Sztul, M. M. Rausch, and S. L. Rose. 2011. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecologic Oncology 122 (2):396–401. doi: 10.1016/j.ygyno.2011.04.027.
  • Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2 (3):161–74. doi: 10.1038/nrc745.
  • Everard, A., L. Geurts, M. Van Roye, N. M. Delzenne, and P. D. Cani. 2012. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One 7 (3):e33858. doi: 10.1371/journal.pone.0033858.
  • Fang, S., J. M. Suh, S. M. Reilly, E. Yu, O. Osborn, D. Lackey, E. Yoshihara, A. Perino, S. Jacinto, Y. Lukasheva, et al. 2015. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nature Medicine 21 (2):159–65. doi: 10.1038/nm.3760.
  • Farquhar, M. G., and G. E. Palade. 1963. Junctional complexes in various epithelia. The Journal of Cell Biology 17:375–412. doi: 10.1083/jcb.17.2.375.
  • Festa, M., A. Capasso, C. W. D'Acunto, M. Masullo, A. G. Rossi, C. Pizza, and S. Piacente. 2011. Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways. Journal of Natural Products 74 (12):2505–13. doi: 10.1021/np200390x.
  • Fiesel, A., D. K. Gessner, E. Most, and K. Eder. 2014. Effects of dietary polyphenol-rich plant products from grape or hop on pro-inflammatory gene expression in the intestine, nutrient digestibility and faecal microbiota of weaned pigs. BMC Veterinary Research 10 (1):196. doi: 10.1186/s12917-014-0196-5.
  • Furukawa, S., T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 114 (12):1752–61. doi: 10.1172/JCI21625.
  • Gallo, C., K. Dallaglio, B. Bassani, T. Rossi, A. Rossello, D. M. Noonan, G. D'Uva, A. Bruno, and A. Albini. 2016. Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation. Oncotarget 7 (37):59917–31. doi: 10.18632/oncotarget.10990.
  • Gerhauser, C., A. Alt, E. Heiss, A. Gamal-Eldeen, K. Klimo, J. Knauft, I. Neumann, H.-R. Scherf, N. Frank, H. Bartsch, et al. 2002. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Molecular Cancer Therapeutics 1 (11):959–69.,
  • Gorjanović, S., F. T. Pastor, R. Vasić, M. Novaković, M. Simonović, S. Milić, and D. Sužnjević. 2013. Electrochemical versus spectrophotometric assessment of antioxidant activity of hop (Humulus lupulus L.) products and individual compounds. Journal of Agricultural and Food Chemistry 61 (38):9089–96. doi: 10.1021/jf401718z.
  • Hanske, L., R. Hussong, N. Frank, C. Gerhäuser, M. Blaut, and A. Braune. 2005. Xanthohumol does not affect the composition of rat intestinal microbiota. Molecular Nutrition & Food Research 49 (9):868–73. doi: 10.1002/mnfr.200500048.
  • Hanske, L., G. Loh, S. Sczesny, M. Blaut, and A. Braune. 2010. Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Molecular Nutrition & Food Research 54 (10):1405–13. doi: 10.1002/mnfr.200900517.
  • Hansson, G. K., and P. Libby. 2006. The immune response in atherosclerosis: A double-edged sword. Nature Reviews Immunology 6 (7):508–19. doi: 10.1038/nri1882.
  • Harikumar, K. B., A. B. Kunnumakkara, K. S. Ahn, P. Anand, S. Krishnan, S. Guha, and B. B. Aggarwal. 2009. Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells . Blood 113 (9):2003–13. doi: 10.1182/blood-2008-04-151944.
  • Henderson, M. C., C. L. Miranda, J. F. Stevens, M. L. Deinzer, and D. R. Buhler. 2000. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30 (3):235–51. doi: 10.1080/004982500237631.
  • Herrington, W., B. Lacey, P. Sherliker, J. Armitage, and S. Lewington. 2016. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circulation Research 118 (4):535–46. doi: 10.1161/CIRCRESAHA.115.307611.
  • Hirata, H.,. K. Takazumi, S. Segawa, Y. Okada, N. Kobayashi, T. Shigyo, and H. Chiba. 2012a. Xanthohumol, a prenylated chalcone from Humulus lupulus L., inhibits cholesteryl ester transfer protein. Food Chemistry 134 (3):1432–7. doi: 10.1016/j.foodchem.2012.03.043.
  • Hirata, H.,. Yimin, Segawa, S. Ozaki, M. Kobayashi, N. Shigyo, T. and Chiba. H. 2012b. Xanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice. PLoS One 7:e49415. doi: 10.1371/journal.pone.0049415.
  • Jaskula, B., P. Kafarski, G. Aerts, and L. De Cooman. 2008. A kinetic study on the isomerization of hop alpha-acids. Journal of Agricultural and Food Chemistry 56 (15):6408–15. doi: 10.1021/jf8004965.
  • Karabín, M., L. Jelínek, T. Kinčl, T. Hudcová, B. Kotlíková, and P. Dostálek. 2013. New approach to the production of xanthohumol-enriched beers. Journal of the Institute of Brewing 119:98–102.
  • Kim, J.-A., Y. Kang, D. Thapa, J. S. Lee, M. A. Park, K. H. Lee, W. S. Lyoo, and Y. R. Lee. 2009. Anti-invasive and anti-angiogenic effects of xanthohumol and its synthetic derivatives. Biomolecules and Therapeutics 17 (4):422–9. doi: 10.4062/biomolther.2009.17.4.422.
  • Kim, K. J., B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 (6423):841–4. doi: 10.1038/362841a0.
  • Kim, S. Y., I. S. Lee, and A. Moon. 2013. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells. Chemico-Biological Interactions 203 (3):565–72. doi: 10.1016/j.cbi.2013.03.012.
  • Kirkwood, J. S., L. L. Legette, C. L. Miranda, Y. Jiang, and J. F. Stevens. 2013. A metabolomics-driven elucidation of the anti-obesity mechanisms of xanthohumol. The Journal of Biological Chemistry 288 (26):19000–13. doi: 10.1074/jbc.M112.445452.
  • Konda, V. R., A. Desai, G. Darland, J. S. Bland, and M. L. Tripp. 2009. Rho iso-alpha acids from hops inhibit the GSK-3/NF-kappaB pathway and reduce inflammatory markers associated with bone and cartilage degradation. Journal of Inflammation (London, England) 6:26. doi: 10.1186/1476-9255-6-26.
  • Kotecha, R., A. Takami, and J. L. Espinoza. 2016. Dietary phytochemicals and cancer chemoprevention: A review of the clinical evidence. Oncotarget 7 (32):52517–29. doi: 10.18632/oncotarget.9593.
  • König, J., J. Wells, P. D. Cani, C. L. García-Ródenas, T. MacDonald, A. Mercenier, J. Whyte, F. Troost, and R.-J. Brummer. 2016. Human intestinal barrier function in health and disease. Clinical and Translational Gastroenterology 7 (10):e196–e196. doi: 10.1038/ctg.2016.54.
  • Lagouge, M., C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (6):1109–22. doi: 10.1016/j.cell.2006.11.013.
  • Lamy, V., S. Roussi, M. Chaabi, F. Gossé, A. Lobstein, and F. Raul. 2008. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells. Apoptosis 13 (10):1232–42. doi: 10.1007/s10495-008-0250-5.
  • Lamy, V., S. Roussi, M. Chaabi, F. Gossé, N. Schall, A. Lobstein, and F. Raul. 2007. Chemopreventive effects of lupulone, a hop β-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 28 (7):1575–81. doi: 10.1093/carcin/bgm080.
  • Lee, I.-S., J. Lim, J. Gal, J. C. Kang, H. J. Kim, B. Y. Kang, and H. J. Choi. 2011. Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochemistry International 58 (2):153–60. doi: 10.1016/j.neuint.2010.11.008.
  • Lee, J., N. Koo, and D. B. Min. 2004. Reactive oxygen species, aging, and antioxidative nutraceuticals. Comprehensive Reviews in Food Science and Food Safety 3 (1):21–33. doi: 10.1111/j.1541-4337.2004.tb00058.x.
  • Lee, J.-C., J. K. Kundu, D.-M. Hwang, H.-K. Na, and Y.-J. Surh. 2007. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets. Carcinogenesis 28 (7):1491–8. doi: 10.1093/carcin/bgm054.
  • Lee, M. S., Y. Shin, S. Jung, and Y. Kim. 2017. Effects of epigallocatechin-3-gallate on thermogenesis and mitochondrial biogenesis in brown adipose tissues of diet-induced obese mice. Food & Nutrition Research 61 (1):1325307. doi: 10.1080/16546628.2017.1325307.
  • Legette, L., C. Karnpracha, R. L. Reed, J. Choi, G. Bobe, J. M. Christensen, R. Rodriguez-Proteau, J. Q. Purnell, and J. F. Stevens. 2014. Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Molecular Nutrition & Food Research 58 (2):248–55. doi: 10.1002/mnfr.201300333.
  • Legette, L., L. Ma, R. L. Reed, C. L. Miranda, J. M. Christensen, R. Rodriguez-Proteau, and J. F. Stevens. 2012. Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration. Molecular Nutrition & Food Research 56 (3):466–74. doi: 10.1002/mnfr.201100554.
  • Legette, L. L., A. Y. Moreno Luna, R. L. Reed, C. L. Miranda, G. Bobe, R. R. Proteau, and J. F. Stevens. 2013. Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats. Phytochemistry 91:236–41. doi: 10.1016/j.phytochem.2012.04.018.
  • Li, B., L. A. Nolte, J. S. Ju, D. H. Han, T. Coleman, J. O. Holloszy, and C. F. Semenkovich. 2000. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nature Medicine 6 (10):1115–20. doi: 10.1038/80450.
  • Liu, M., H. Yin, G. Liu, J. Dong, Z. Qian, and J. Miao. 2014. Xanthohumol, a prenylated chalcone from beer hops, acts as an α-glucosidase inhibitor in vitro. Journal of Agricultural and Food Chemistry 62 (24):5548–54. doi: 10.1021/jf500426z.
  • Liu, T., L. Zhang, D. Joo, and S.-C. Sun. 2017. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy 2:17023.
  • Luescher, S., C. Urmann, and V. Butterweck. 2017. Effect of hops derived prenylated phenols on TNF-α induced barrier dysfunction in intestinal epithelial cells. Journal of Natural Products 80 (4):925–31. doi: 10.1021/acs.jnatprod.6b00869.
  • Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. The Journal of Clinical Investigation 117 (1):175–84. doi: 10.1172/JCI29881.
  • Lupinacci, E., J. Meijerink, J.-P. Vincken, B. Gabriele, H. Gruppen, and R. F. Witkamp. 2009. Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes. Journal of Agricultural and Food Chemistry 57 (16):7274–81. doi: 10.1021/jf901244k.
  • Lv, H., Q. Liu, Z. Wen, H. Feng, X. Deng, and X. Ci. 2017. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biology 12:311–24. doi: 10.1016/j.redox.2017.03.001.
  • Ma, H., and M. E. Patti. 2014. Bile acids, obesity, and the metabolic syndrome. Best Practice & Research. Clinical Gastroenterology 28 (4):573–83. doi: 10.1016/j.bpg.2014.07.004.
  • Mannering, G. J., J. A. Shoeman, and L. B. Deloria. 1992. Identification of the antibiotic hops component, colupulone, as an inducer of hepatic cytochrome P-4503A in the mouse. Drug Metabolism and Disposition: The Biological Fate of Chemicals 20 (2):142–7.
  • Marchiando, A. M., L. Shen, W. V. Graham, K. L. Edelblum, C. A. Duckworth, Y. Guan, M. H. Montrose, J. R. Turner, and A. J. Watson. 2011. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140 (4):1208–18. doi: 10.1053/j.gastro.2011.01.004.
  • Masson, V., L. R. de la Ballina, C. Munaut, B. Wielockx, M. Jost, C. Maillard, S. Blacher, K. Bajou, T. Itoh, S. Itohara, et al. 2005. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB Journal 19 (2):234–6. doi: 10.1096/fj.04-2140fje.
  • Maukonen, J., K.-L. Kolho, M. Paasela, J. Honkanen, P. Klemetti, O. Vaarala, and M. Saarela. 2015. Altered fecal microbiota in paediatric inflammatory bowel disease. Journal of Crohn's and Colitis 9 (12):1088–95. doi: 10.1093/ecco-jcc/jjv147.
  • Mazmanian, S. K., C. H. Liu, A. O. Tzianabos, and D. L. Kasper. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122 (1):107–18. doi: 10.1016/j.cell.2005.05.007.
  • Milligan, S. R., J. C. Kalita, V. Pocock, V. Van De Kauter, J. F. Stevens, M. L. Deinzer, H. Rong, and D. De Keukeleire. 2000. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. The Journal of Clinical Endocrinology and Metabolism 85 (12):4912–15. doi: 10.1210/jcem.85.12.7168.
  • Miranda, C. L., G. L. Aponso, J. F. Stevens, M. L. Deinzer, and D. R. Buhler. 2000. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Letters 149 (1-2):21–9. doi: 10.1016/S0304-3835(99)00328-6.
  • Miranda, C. L., V. D. Elias, J. J. Hay, J. Choi, R. L. Reed, and J. F. Stevens. 2016. Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice. Archives of Biochemistry and Biophysics 599:22–30. doi: 10.1016/j.abb.2016.03.008.
  • Miranda, C. L., J. F. Stevens, A. Helmrich, M. C. Henderson, R. J. Rodriguez, Y. H. Yang, M. L. Deinzer, D. W. Barnes, and D. R. Buhler. 1999. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food and Chemical Toxicology 37 (4):271–85. doi: 10.1016/S0278-6915(99)00019-8.
  • Miura, Y., M. Hosono, C. Oyamada, H. Odai, S. Oikawa, and K. Kondo. 2005. Dietary isohumulones, the bitter components of beer, raise plasma HDL-cholesterol levels and reduce liver cholesterol and triacylglycerol contents similar to PPARα activations in C57BL/6 mice. British Journal of Nutrition 93 (4):559–67. doi: 10.1079/BJN20041384.
  • Monteiro, R., C. Calhau, A. O. Silva, S. Pinheiro-Silva, S. Guerreiro, F. Gärtner, I. Azevedo, and R. Soares. 2008. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. Journal of Cellular Biochemistry 104 (5):1699–707. doi: 10.1002/jcb.21738.
  • Morimoto-Kobayashi, Y., K. Ohara, H. Ashigai, T. Kanaya, K. Koizumi, F. Manabe, Y. Kaneko, Y. Taniguchi, M. Katayama, Y. Kowatari, et al. 2015. Matured hop extract reduces body fat in healthy overweight humans: A randomized, double-blind, placebo-controlled parallel group study. Nutrition Journal 15 (1):25. doi: 10.1186/s12937-016-0144-2.
  • Morimoto-Kobayashi, Y., K. Ohara, C. Takahashi, S. Kitao, G. Wang, Y. Taniguchi, M. Katayama, and K. Nagai. 2015. Matured hop bittering components induce thermogenesis in brown adipose tissue via sympathetic nerve activity. PLoS One 10 (6):e0131042. doi: 10.1371/journal.pone.0131042.
  • Murakami, A., P. Darby, B. Javornik, M. S. Pais, E. Seigner, A. Lutz, and P. Svoboda. 2006. Molecular phylogeny of wild hops, Humulus lupulus L. Heredity 97 (1):66–74. doi: 10.1038/sj.hdy.6800839.
  • Murri, M.,. I. Leiva, J. M. Gomez-Zumaquero, F. J. Tinahones, F. Cardona, F. Soriguer, and M. I. Queipo-Ortuño. 2013. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Medicine 11:46. doi: 10.1186/1741-7015-11-46.
  • Musaiger, A. O., and H. M. Al-Hazzaa. 2012. Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. International Journal of General Medicine 5:199–217. doi: 10.2147/IJGM.S29663.
  • Namikoshi, T., N. Tomita, S. Fujimoto, Y. Haruna, M. Ohzeki, N. Komai, T. Sasaki, A. Yoshida, and N. Kashihara. 2007. Isohumulones derived from hops ameliorate renal injury via an anti-oxidative effect in dahl salt-sensitive rats. Hypertension Research 30 (2):175–84. doi: 10.1291/hypres.30.175.
  • Naya, Y., and M. Kotake. 1971. The constituents of hops. VI studies of the volatile composition of Humulus lupulus L. during ripening. Bulletin of the Chemical Society of Japan 44 (11):3116–20. doi: 10.1246/bcsj.44.3116.
  • Noda, S., S. Tanabe, and T. Suzuki. 2013. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells. Molecular Nutrition & Food Research 57 (11):2019–28. doi: 10.1002/mnfr.201300045.
  • Nowakowska, Z. 2007. A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry. 42 (2):125–37. doi: 10.1016/j.ejmech.2006.09.019.
  • Nozawa, H. 2005. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochemical and Biophysical Research Communications 336 (3):754–61. doi: 10.1016/j.bbrc.2005.08.159.
  • Nozawa, H., W. Nakao, F. Zhao, and K. Kondo. 2005. Dietary supplement of isohumulones inhibits the formation of aberrant crypt foci with a concomitant decrease in prostaglandin E2 level in rat colon. Molecular Nutrition & Food Research 49 (8):772–8. doi: 10.1002/mnfr.200500027.
  • Obara, K., M. Mizutani, Y. Hitomi, H. Yajima, and K. Kondo. 2009. Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes. Clinical Nutrition (Edinburgh, Scotland) 28 (3):278–84. doi: 10.1016/j.clnu.2009.03.012.
  • Odenwald, M. A., and J. R. Turner. 2017. The intestinal epithelial barrier: A therapeutic target? Nature Reviews. Gastroenterology & Hepatology 14 (1):9–21. doi: 10.1038/nrgastro.2016.169.
  • Pan, L., H. Becker, and C. Gerhäuser. 2005. Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Molecular Nutrition & Food Research 49 (9):837–43. doi: 10.1002/mnfr.200500065.
  • Pang, Y., D. Nikolic, D. Zhu, L. R. Chadwick, G. F. Pauli, N. R. Farnsworth, and R. Bv. Breemen. 2007. Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Molecular Nutrition & Food Research 51 (7):872–9. doi: 10.1002/mnfr.200600252.
  • Paraiso, I. L., L. S. Plagmann, L. Yang, R. Zielke, A. F. Gombart, C. S. Maier, A. E. Sikora, P. R. Blakemore, and J. F. Stevens. 2019. Reductive metabolism of xanthohumol and 8-Prenylnaringenin by the intestinal bacterium Eubacterium ramulus. Molecular Nutrition & Food Research 63 (2):e1800923. doi: 10.1002/mnfr.201800923.
  • Peery, A. F., S. D. Crockett, C. C. Murphy, J. L. Lund, E. S. Dellon, J. L. Williams, E. T. Jensen, N. J. Shaheen, A. S. Barritt, S. R. Lieber, et al. 2019. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 156 (1):254–72. doi: 10.1053/j.gastro.2018.08.063.
  • Pisoschi, A. M., and A. Pop. 2015. The role of antioxidants in the chemistry of oxidative stress: A review. European Journal of Medicinal Chemistry 97:55–74. doi: 10.1016/j.ejmech.2015.04.040.
  • Plazar, J., B. Zegura, T. T. Lah, and M. Filipic. 2007. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutation Research 632 (1–2):1–8. doi: 10.1016/j.mrgentox.2007.03.013.
  • Popkin, B. M. 2002. An overview on the nutrition transition and its health implications: The Bellagio meeting. Public Health Nutrition 5 (1A):93–103. doi: 10.1079/phn2001280.
  • Popkin, B. M., and P. Gordon-Larsen. 2004. The nutrition transition: Worldwide obesity dynamics and their determinants. International Journal of Obesity and Related Metabolic Disorders 28 (Suppl 3):S2–S9. doi: 10.1038/sj.ijo.0802804.
  • Possemiers, S., A. Heyerick, V. Robbens, D. De Keukeleire, and W. Verstraete. 2005. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. Journal of Agricultural and Food Chemistry 53 (16):6281–8. doi: 10.1021/jf0509714.
  • Ramos, S. 2008. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Molecular Nutrition & Food Research 52 (5):507–26. doi: 10.1002/mnfr.200700326.
  • Rancán, L., S. D. Paredes, I. García, P. Muñoz, C. García, G. López de Hontanar, M. de la Fuente, E. Vara, and J. A. F. Tresguerres. 2017. Protective effect of xanthohumol against age-related brain damage. Journal of Nutritional Biochemistry. 49:133–40. doi: 10.1016/j.jnutbio.2017.07.011.
  • Saito, K., Y. Matsuo, H. Imafuji, T. Okubo, Y. Maeda, T. Sato, T. Shamoto, K. Tsuboi, M. Morimoto, H. Takahashi, et al. 2018. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Cancer Science 109 (1):132–40. doi: 10.1111/cas.13441.
  • Saklayen, M. G. 2018. The global epidemic of the metabolic syndrome. Current Hypertension Reports 20 (2):12. doi: 10.1007/s11906-018-0812-z.
  • Samuels, J. S., R. Shashidharamurthy, and S. Rayalam. 2018. Novel anti-obesity effects of beer hops compound xanthohumol: Role of AMPK signaling pathway. Nutrition & Metabolism (London) 15:42. doi: 10.1186/s12986-018-0277-8.
  • Shimada, T., C. L. Hayes, H. Yamazaki, S. Amin, S. S. Hecht, F. P. Guengerich, and T. R. Sutter. 1996. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Research 56 (13):2979–84.
  • Shimamura, M., T. Hazato, H. Ashino, Y. Yamamoto, E. Iwasaki, H. Tobe, K. Yamamoto, and S. Yamamoto. 2001. Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Biochemical and Biophysical Research Communications 289 (1):220–4. doi: 10.1006/bbrc.2001.5934.
  • Siegel, L., A. Miternique-Grosse, C. Griffon, C. Klein-Soyer, A. Lobstein, F. Raul, and D. Stephan. 2008. Antiangiogenic properties of lupulone, a bitter acid of hop cones. Anticancer Research 28 (1A):289–94.
  • Small, E. 1978. A numerical and nomenclatural analysis of morpho-geographic taxa of Humulus. Systematic Botany 3 (1):37–76. doi: 10.2307/2418532.
  • Stevens, J. F., and J. E. Page. 2004. Xanthohumol and related prenylflavonoids from hops and beer: To your good health! Phytochemistry 65 (10):1317–30. doi: 10.1016/j.phytochem.2004.04.025.
  • Stevens, J. F., A. W. Taylor, J. E. Clawson, and M. L. Deinzer. 1999. Fate of xanthohumol and related prenylflavonoids from hops to beer. Journal of Agricultural and Food Chemistry 47 (6):2421–8. doi: 10.1021/jf990101k.
  • Sun, R., N. Yang, B. Kong, B. Cao, D. Feng, X. Yu, C. Ge, J. Huang, J. Shen, P. Wang, et al. 2017. Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway. Molecular Pharmacology 91 (2):110–22. doi: 10.1124/mol.116.106617.
  • Sun, X., M. Du, D. A. Navarre, and M.-J. Zhu. 2018. Purple potato extract promotes intestinal epithelial differentiation and barrier function by activating AMP-activated protein kinase. Molecular Nutrition & Food Research 62 (4):1700536. doi: 10.1002/mnfr.201700536.
  • Surh, Y.-J. 2003. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3 (10):768–80. doi: 10.1038/nrc1189.
  • Suzuki, T., and H. Hara. 2009. Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. The Journal of Nutrition 139 (5):965–74. doi: 10.3945/jn.108.100867.
  • Suzuki, T., S. Tanabe, and H. Hara. 2011. Kaempferol enhances intestinal barrier function through the cytoskeletal association and expression of tight junction proteins in Caco-2 cells. The Journal of Nutrition 141 (1):87–94. doi: 10.3945/jn.110.125633.
  • Tagashira, M., M. Watanabe, and N. Uemitsu. 1995. Antioxidative activity of hop bitter acids and their analogues. Bioscience, Biotechnology, and Biochemistry 59 (4):740–2. doi: 10.1271/bbb.59.740.
  • Tang, W., L.-H. Chen, H. Daun, C.-T. Ho, and M.-H. Pan. 2011. Inhibitory effects of hexahydro-β-acids in LPS-stimulated murine macrophage. Journal of Functional Foods. 3 (3):215–22. doi: 10.1016/j.jff.2011.04.004.
  • Tillman, G. E., G. J. Haas, M. G. Wise, B. Oakley, M. A. Smith, and G. R. Siragusa. 2011. Chicken intestine microbiota following the administration of lupulone, a hop-based antimicrobial. FEMS Microbiology Ecology 77 (2):395–403. doi: 10.1111/j.1574-6941.2011.01119.x.
  • Valko, M., D. Leibfritz, J. Moncol, M. T. Cronin, M. Mazur, and J. Telser. 2007. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology 39 (1):44–84. doi: 10.1016/j.biocel.2006.07.001.
  • Van Cleemput, M., A. Heyerick, C. Libert, K. Swerts, J. Philippé, D. D. Keukeleire, G. Haegeman, and K. D. Bosscher. 2009. Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma. Molecular Nutrition & Food Research 53 (9):1143–55. doi: 10.1002/mnfr.200800493.
  • van Marken Lichtenbelt, W. D., J. W. Vanhommerig, N. M. Smulders, J. M. Drossaerts, G. J. Kemerink, N. D. Bouvy, P. Schrauwen, and G. J. Teule. 2009. Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine 360 (15):1500–8. doi: 10.1056/NEJMoa0808718.
  • Vanhoecke, B., L. Derycke, V. V. Marck, H. Depypere, D. D. Keukeleire, and M. Bracke. 2005. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. International Journal of Cancer 117 (6):889–95. doi: 10.1002/ijc.21249.
  • Vetrano, S., M. Rescigno, M. R. Cera, C. Correale, C. Rumio, A. Doni, M. Fantini, A. Sturm, E. Borroni, A. Repici, et al. 2008. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 135 (1):173–84. doi: 10.1053/j.gastro.2008.04.002.
  • Wang, S., X. Liang, Q. Yang, X. Fu, C. J. Rogers, M. Zhu, B. D. Rodgers, Q. Jiang, M. V. Dodson, and M. Du. 2015. Resveratrol induces brown-like adipocyte formation in white fat through activation of AMP-activated protein kinase (AMPK) α1. International Journal of Obesity (2005) 39 (6):967–76. doi: 10.1038/ijo.2015.23.
  • Ward, B. W., J. S. Schiller, and R. A. Goodman. 2014. Multiple chronic conditions among US adults: A 2012 update. Preventing Chronic Disease 11:E62. doi: 10.5888/pcd11.130389.
  • Watanabe, M., S. M. Houten, C. Mataki, M. A. Christoffolete, B. W. Kim, H. Sato, N. Messaddeq, J. W. Harney, O. Ezaki, T. Kodama, et al. 2006. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439 (7075):484–9., doi: 10.1038/nature04330.
  • Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante. 2003. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation 112 (12):1796–808. doi: 10.1172/JCI200319246.
  • West, C. E., Renz, H. Jenmalm, M. C. Kozyrskyj, A. L. Allen, K. J. Vuillermin, P. Prescott, S. L., in-FLAME Microbiome Interest Group. 2015. The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies. The Journal of Allergy and Clinical Immunology 135 (1):3–13; quiz 14. doi: 10.1016/j.jaci.2014.11.012.
  • Wu, S. H., W. S. Hui, Z. Liu, and S. C. Ho. 2010. Metabolic syndrome and all-cause mortality: A meta-analysis of prospective cohort studies. European Journal of Epidemiology 25 (6):375–84. doi: 10.1007/s10654-010-9459-z.
  • Xing, T., Y. Kang, X. Xu, B. Wang, M. Du, and M. J. Zhu. 2018. Raspberry supplementation improves insulin signaling and promotes brown-like adipocyte development in white adipose tissue of obese mice. Molecular Nutrition & Food Research 62:1701035.
  • Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112 (12):1821–30. doi: 10.1172/JCI200319451.
  • Xuan, N. T., E. Shumilina, E. Gulbins, S. Gu, F. Götz, and F. Lang. 2010. Triggering of dendritic cell apoptosis by xanthohumol. Molecular Nutrition & Food Research 54 (S2):S214–S224. doi: 10.1002/mnfr.200900324.
  • Yaffe, K., A. Kanaya, K. Lindquist, E. M. Simonsick, T. Harris, R. I. Shorr, F. A. Tylavsky, and A. B. Newman. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 (18):2237–42. doi: 10.1001/jama.292.18.2237.
  • Yajima, H., E. Ikeshima, M. Shiraki, T. Kanaya, D. Fujiwara, H. Odai, N. Tsuboyama-Kasaoka, O. Ezaki, S. Oikawa, and K. Kondo. 2004. Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. The Journal of Biological Chemistry 279 (32):33456–62. doi: 10.1074/jbc.M403456200.
  • Yajima, H., T. Noguchi, E. Ikeshima, M. Shiraki, T. Kanaya, N. Tsuboyama-Kasaoka, O. Ezaki, S. Oikawa, and K. Kondo. 2005. Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents. International Journal of Obesity (2005) 29 (8):991–7. doi: 10.1038/sj.ijo.0802965.
  • Yamaguchi, N., K. Satoh-Yamaguchi, and M. Ono. 2009. In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine 16 (4):369–76. doi: 10.1016/j.phymed.2008.12.021.
  • Yamamoto, K., J. Wang, S. Yamamoto, and H. Tobe. 2000. Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid. FEBS Letters 465 (2–3):103–6. doi: 10.1016/S0014-5793(99)01727-5.
  • Yamazaki, T., Y. Morimoto-Kobayashi, K. Koizumi, C. Takahashi, S. Nakajima, S. Kitao, Y. Taniguchi, M. Katayama, and Y. Ogawa. 2019. Secretion of a gastrointestinal hormone, cholecystokinin, by hop-derived bitter components activates sympathetic nerves in brown adipose tissue. The Journal of Nutritional Biochemistry 64:80–7. doi: 10.1016/j.jnutbio.2018.10.009.
  • Yoneshiro, T., S. Aita, Y. Kawai, T. Iwanaga, and M. Saito. 2012. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. The American Journal of Clinical Nutrition 95 (4):845–50. doi: 10.3945/ajcn.111.018606.
  • Yoneshiro, T., S. Aita, M. Matsushita, T. Kayahara, T. Kameya, Y. Kawai, T. Iwanaga, and M. Saito. 2013. Recruited brown adipose tissue as an antiobesity agent in humans. The Journal of Clinical Investigation 123 (8):3404–8. doi: 10.1172/JCI67803.
  • Yui, K., A. Kiyofuji, and K. Osada. 2014. Effects of xanthohumol-rich extract from the hop on fatty acid metabolism in rats fed a high-fat diet. Journal of Oleo Science 63 (2):159–68. doi: 10.5650/jos.ess13136.
  • Zanoli, P., and M. Zavatti. 2008. Pharmacognostic and pharmacological profile of Humulus lupulus L. Journal of Ethnopharmacology 116 (3):383–96. doi: 10.1016/j.jep.2008.01.011.
  • Zeissig, S., N. Burgel, D. Gunzel, J. Richter, J. Mankertz, U. Wahnschaffe, A. J. Kroesen, M. Zeitz, M. Fromm, and J. D. Schulzke. 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (1):61–72. doi: 10.1136/gut.2006.094375.
  • Zhang, X., X. Liang, H. Xiao, and Q. Xu. 2004. Direct characterization of bitter acids in a crude hop extract by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Journal of the American Society for Mass Spectrometry 15 (2):180–7. doi: 10.1016/j.jasms.2003.09.014.
  • Zhang, Y. J., R. Y. Gan, S. Li, Y. Zhou, A. N. Li, D. P. Xu, and H. B. Li. 2015. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules (Basel, Switzerland) 20 (12):21138–56. doi: 10.3390/molecules201219753.
  • Zhang, Z.,. H. Zhang, B. Li, X. Meng, J. Wang, Y. Zhang, S. Yao, Q. Ma, L. Jin, J. Yang, et al. 2014. Berberine activates thermogenesis in white and brown adipose tissue. Nature Communications 5:5493. doi: 10.1038/ncomms6493.
  • Zhao, F., H. Nozawa, A. Daikonnya, K. Kondo, and S. Kitanaka. 2003. Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biological and Pharmaceutical Bulletin 26 (1):61–5. doi: 10.1248/bpb.26.61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.